HIV in pregnancy: Identification of intrapartum and perinatal HIV exposures
Abstract The benefits of human immunodeficiency virus (HIV) testing in pregnancy, when combined with appropriate maternal antiretroviral therapy and intrapartum and postnatal prophylaxis, are well established. The vertical rate of transmission of HIV in North America is now well below 2%. Efforts mu...
Gespeichert in:
| Veröffentlicht in: | Paediatrics & child health 2019-02, Vol.24 (1), p.42-45 |
|---|---|
| Hauptverfasser: | , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 45 |
|---|---|
| container_issue | 1 |
| container_start_page | 42 |
| container_title | Paediatrics & child health |
| container_volume | 24 |
| creator | Moore, Dorothy L Allen, Upton D |
| description | Abstract
The benefits of human immunodeficiency virus (HIV) testing in pregnancy, when combined with appropriate maternal antiretroviral therapy and intrapartum and postnatal prophylaxis, are well established. The vertical rate of transmission of HIV in North America is now well below 2%. Efforts must continue to ensure that these benefits are sustained. Women who have received little or no prenatal care and those who present for delivery with unknown HIV status need immediate testing. As more infants are exposed to antiretroviral agents, strategies need to be implemented to ensure adequate follow-up of these infants. Issues relating to the identification of HIV-exposed infants are highlighted. |
| doi_str_mv | 10.1093/pch/pxy181 |
| format | Article |
| fullrecord | <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6376313</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A615533930</galeid><oup_id>10.1093/pch/pxy181</oup_id><sourcerecordid>A615533930</sourcerecordid><originalsourceid>FETCH-LOGICAL-c503t-fe88576e6546d3ecc7b140c4add292560ae59e3fd275a428a6bc1c805b9b1ef63</originalsourceid><addsrcrecordid>eNp9kVtrFTEUhYMo9qIv_gAZEEGEaXOZZDI-CKXU9mDBF_U1ZDI7pykzSUxmpOffm8OprS1S8pCQ_a21s7MQekPwEcEdO47m6jjebIgkz9A-6YisSSP583KmmNctlnIPHeR8jXFDJKYv0R7DkjFJun309WL1s3K-ignWXnuz-VStBvCzs87o2QVfBVvqc9JRp3mZKu2HKkJyXs96rLZquIkhLwnyK_TC6jHD69v9EP34cvb99KK-_Ha-Oj25rA3HbK4tSMlbAYI3YmBgTNuTBptGDwPtKBdYA--A2YG2XDdUatEbYiTmfdcTsIIdos8737j0EwwGts8bVUxu0mmjgnbqYcW7K7UOv5VgrWCEFYMPtwYp_Fogz2py2cA4ag9hyYoSKSmWlNCCvnuEXocl-TKeogxj0UgpuntqrUdQzttQ-pqtqToRhHPGOoYLdfQfqqwBJmeCB-vK_QPBx53ApJBzAns3I8FqG70q0atd9AV----v3KF_sy7A-x0QlviU0R_v0rZq</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2300648869</pqid></control><display><type>article</type><title>HIV in pregnancy: Identification of intrapartum and perinatal HIV exposures</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Oxford University Press Journals All Titles (1996-Current)</source><source>PubMed Central</source><creator>Moore, Dorothy L ; Allen, Upton D</creator><creatorcontrib>Moore, Dorothy L ; Allen, Upton D</creatorcontrib><description>Abstract
The benefits of human immunodeficiency virus (HIV) testing in pregnancy, when combined with appropriate maternal antiretroviral therapy and intrapartum and postnatal prophylaxis, are well established. The vertical rate of transmission of HIV in North America is now well below 2%. Efforts must continue to ensure that these benefits are sustained. Women who have received little or no prenatal care and those who present for delivery with unknown HIV status need immediate testing. As more infants are exposed to antiretroviral agents, strategies need to be implemented to ensure adequate follow-up of these infants. Issues relating to the identification of HIV-exposed infants are highlighted.</description><identifier>ISSN: 1205-7088</identifier><identifier>EISSN: 1918-1485</identifier><identifier>DOI: 10.1093/pch/pxy181</identifier><identifier>PMID: 30833819</identifier><language>eng</language><publisher>US: Oxford University Press</publisher><subject>Antiretroviral agents ; Antiretroviral drugs ; Babies ; Childbirth & labor ; Highly active antiretroviral therapy ; HIV ; HIV tests ; Human exposure ; Human immunodeficiency virus ; Infants ; Medical tests ; Patient care ; Pediatrics ; Position Statement and Practice Points / Documents de Principes et Points de Pratique ; Pregnancy ; Pregnant women ; Prenatal care ; Prophylaxis ; Retirement benefits</subject><ispartof>Paediatrics & child health, 2019-02, Vol.24 (1), p.42-45</ispartof><rights>Canadian Paediatric Society 2019. Published by Oxford University Press on behalf of the Canadian Paediatric Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com 2019</rights><rights>COPYRIGHT 2019 Oxford University Press</rights><rights>Canadian Paediatric Society 2019. Published by Oxford University Press on behalf of the Canadian Paediatric Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c503t-fe88576e6546d3ecc7b140c4add292560ae59e3fd275a428a6bc1c805b9b1ef63</citedby><cites>FETCH-LOGICAL-c503t-fe88576e6546d3ecc7b140c4add292560ae59e3fd275a428a6bc1c805b9b1ef63</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6376313/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6376313/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,724,777,781,882,1579,27905,27906,53772,53774</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30833819$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Moore, Dorothy L</creatorcontrib><creatorcontrib>Allen, Upton D</creatorcontrib><title>HIV in pregnancy: Identification of intrapartum and perinatal HIV exposures</title><title>Paediatrics & child health</title><addtitle>Paediatr Child Health</addtitle><description>Abstract
The benefits of human immunodeficiency virus (HIV) testing in pregnancy, when combined with appropriate maternal antiretroviral therapy and intrapartum and postnatal prophylaxis, are well established. The vertical rate of transmission of HIV in North America is now well below 2%. Efforts must continue to ensure that these benefits are sustained. Women who have received little or no prenatal care and those who present for delivery with unknown HIV status need immediate testing. As more infants are exposed to antiretroviral agents, strategies need to be implemented to ensure adequate follow-up of these infants. Issues relating to the identification of HIV-exposed infants are highlighted.</description><subject>Antiretroviral agents</subject><subject>Antiretroviral drugs</subject><subject>Babies</subject><subject>Childbirth & labor</subject><subject>Highly active antiretroviral therapy</subject><subject>HIV</subject><subject>HIV tests</subject><subject>Human exposure</subject><subject>Human immunodeficiency virus</subject><subject>Infants</subject><subject>Medical tests</subject><subject>Patient care</subject><subject>Pediatrics</subject><subject>Position Statement and Practice Points / Documents de Principes et Points de Pratique</subject><subject>Pregnancy</subject><subject>Pregnant women</subject><subject>Prenatal care</subject><subject>Prophylaxis</subject><subject>Retirement benefits</subject><issn>1205-7088</issn><issn>1918-1485</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><recordid>eNp9kVtrFTEUhYMo9qIv_gAZEEGEaXOZZDI-CKXU9mDBF_U1ZDI7pykzSUxmpOffm8OprS1S8pCQ_a21s7MQekPwEcEdO47m6jjebIgkz9A-6YisSSP583KmmNctlnIPHeR8jXFDJKYv0R7DkjFJun309WL1s3K-ignWXnuz-VStBvCzs87o2QVfBVvqc9JRp3mZKu2HKkJyXs96rLZquIkhLwnyK_TC6jHD69v9EP34cvb99KK-_Ha-Oj25rA3HbK4tSMlbAYI3YmBgTNuTBptGDwPtKBdYA--A2YG2XDdUatEbYiTmfdcTsIIdos8737j0EwwGts8bVUxu0mmjgnbqYcW7K7UOv5VgrWCEFYMPtwYp_Fogz2py2cA4ag9hyYoSKSmWlNCCvnuEXocl-TKeogxj0UgpuntqrUdQzttQ-pqtqToRhHPGOoYLdfQfqqwBJmeCB-vK_QPBx53ApJBzAns3I8FqG70q0atd9AV----v3KF_sy7A-x0QlviU0R_v0rZq</recordid><startdate>20190201</startdate><enddate>20190201</enddate><creator>Moore, Dorothy L</creator><creator>Allen, Upton D</creator><general>Oxford University Press</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8FQ</scope><scope>8FV</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ASE</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FPQ</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K6X</scope><scope>K9.</scope><scope>M0S</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20190201</creationdate><title>HIV in pregnancy: Identification of intrapartum and perinatal HIV exposures</title><author>Moore, Dorothy L ; Allen, Upton D</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c503t-fe88576e6546d3ecc7b140c4add292560ae59e3fd275a428a6bc1c805b9b1ef63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Antiretroviral agents</topic><topic>Antiretroviral drugs</topic><topic>Babies</topic><topic>Childbirth & labor</topic><topic>Highly active antiretroviral therapy</topic><topic>HIV</topic><topic>HIV tests</topic><topic>Human exposure</topic><topic>Human immunodeficiency virus</topic><topic>Infants</topic><topic>Medical tests</topic><topic>Patient care</topic><topic>Pediatrics</topic><topic>Position Statement and Practice Points / Documents de Principes et Points de Pratique</topic><topic>Pregnancy</topic><topic>Pregnant women</topic><topic>Prenatal care</topic><topic>Prophylaxis</topic><topic>Retirement benefits</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Moore, Dorothy L</creatorcontrib><creatorcontrib>Allen, Upton D</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Canadian Business & Current Affairs Database</collection><collection>Canadian Business & Current Affairs Database (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Index</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>British Nursing Index (BNI) (1985 to Present)</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>British Nursing Index</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Paediatrics & child health</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Moore, Dorothy L</au><au>Allen, Upton D</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>HIV in pregnancy: Identification of intrapartum and perinatal HIV exposures</atitle><jtitle>Paediatrics & child health</jtitle><addtitle>Paediatr Child Health</addtitle><date>2019-02-01</date><risdate>2019</risdate><volume>24</volume><issue>1</issue><spage>42</spage><epage>45</epage><pages>42-45</pages><issn>1205-7088</issn><eissn>1918-1485</eissn><abstract>Abstract
The benefits of human immunodeficiency virus (HIV) testing in pregnancy, when combined with appropriate maternal antiretroviral therapy and intrapartum and postnatal prophylaxis, are well established. The vertical rate of transmission of HIV in North America is now well below 2%. Efforts must continue to ensure that these benefits are sustained. Women who have received little or no prenatal care and those who present for delivery with unknown HIV status need immediate testing. As more infants are exposed to antiretroviral agents, strategies need to be implemented to ensure adequate follow-up of these infants. Issues relating to the identification of HIV-exposed infants are highlighted.</abstract><cop>US</cop><pub>Oxford University Press</pub><pmid>30833819</pmid><doi>10.1093/pch/pxy181</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1205-7088 |
| ispartof | Paediatrics & child health, 2019-02, Vol.24 (1), p.42-45 |
| issn | 1205-7088 1918-1485 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6376313 |
| source | Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Oxford University Press Journals All Titles (1996-Current); PubMed Central |
| subjects | Antiretroviral agents Antiretroviral drugs Babies Childbirth & labor Highly active antiretroviral therapy HIV HIV tests Human exposure Human immunodeficiency virus Infants Medical tests Patient care Pediatrics Position Statement and Practice Points / Documents de Principes et Points de Pratique Pregnancy Pregnant women Prenatal care Prophylaxis Retirement benefits |
| title | HIV in pregnancy: Identification of intrapartum and perinatal HIV exposures |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T05%3A58%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=HIV%20in%20pregnancy:%20Identification%20of%20intrapartum%20and%20perinatal%20HIV%20exposures&rft.jtitle=Paediatrics%20&%20child%20health&rft.au=Moore,%20Dorothy%20L&rft.date=2019-02-01&rft.volume=24&rft.issue=1&rft.spage=42&rft.epage=45&rft.pages=42-45&rft.issn=1205-7088&rft.eissn=1918-1485&rft_id=info:doi/10.1093/pch/pxy181&rft_dat=%3Cgale_pubme%3EA615533930%3C/gale_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2300648869&rft_id=info:pmid/30833819&rft_galeid=A615533930&rft_oup_id=10.1093/pch/pxy181&rfr_iscdi=true |